Valiant Co.,Ltd

Shenzhen Stock Exchange 002643.SZ

Valiant Co.,Ltd Debt to Equity Ratio for the year ending December 31, 2023: 0.22

Valiant Co.,Ltd Debt to Equity Ratio is 0.22 for the year ending December 31, 2023, a 65.57% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Valiant Co.,Ltd Debt to Equity Ratio for the year ending December 31, 2022 was 0.13, a 48.18% change year over year.
  • Valiant Co.,Ltd Debt to Equity Ratio for the year ending December 31, 2021 was 0.09, a -12.55% change year over year.
  • Valiant Co.,Ltd Debt to Equity Ratio for the year ending December 31, 2020 was 0.10, a 140.22% change year over year.
  • Valiant Co.,Ltd Debt to Equity Ratio for the year ending December 31, 2019 was 0.04, a 2,234.94% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
SV Wall Street
Shenzhen Stock Exchange: 002643.SZ

Valiant Co.,Ltd

CEO Mr. Zhong Li Wang
IPO Date Dec. 20, 2011
Location China
Headquarters 11 Wuzhishan Road
Employees 4,635
Sector Industrials
Industries
Description

Valiant Co.,Ltd. produces and sells chemical materials worldwide. The company offers liquid crystal singles and intermediates, OLED singles and intermediates, PI materials, PR monomer, lithium battery additives, and other electronic chemicals. It also provides automobile exhausts purification materials, flue gas denitrification catalysts, VOCs adsorption catalysts, methanol to olefin catalysts, petroleum cracking catalysts, new energy materials, energy-saving lighting materials, organic solar technology, other supporting materials for new energy vehicles, etc. In addition, the company offers API, pharmaceutical intermediates, pharmaceutical formulations, Chinese medicine, and nutrition and health food; life science products related to drug innovation, genomics, proteomics, metabonomics, food health analysis, etc.; and diagnostic reagent products used for the diagnosis of human diseases, such as AIDS, hepatitis, cancer, dengue, cardiovascular and cerebrovascular diseases, etc., as well as for the detection of drug abuse, endocrine levels, and other human conditions. The company was formerly known as Yantai Valiant Fine Chemicals Co., Ltd. and changed its name to Valiant Co.,Ltd. in May 2015. Valiant Co.,Ltd. was founded in 1992 and is headquartered in Yantai, China.

Similar companies

002498.SZ

Qingdao Hanhe Cable Co.,Ltd

USD 0.45

-1.00%

002597.SZ

Anhui Jinhe Industrial Co.,Ltd.

USD 3.33

1.03%

002572.SZ

Suofeiya Home Collection Co., Ltd.

USD 2.26

2.09%

002602.SZ

Zhejiang Century Huatong Group Co.,Ltd

USD 0.69

3.18%

002624.SZ

Perfect World Co., Ltd.

USD 1.44

2.46%

StockViz Staff

February 3, 2025

Any question? Send us an email